| Symbol | CLDI |
|---|---|
| Name | CALIDI BIOTHERAPEUTICS, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 4475 EXECUTIVE DRIVE, SAN DIEGO, CA 92121 |
| Telephone | 858-794-9600 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001855485 |
| Description | None |
Director Peoples George 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039292
Read moreDirector Leftwich Scott 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039290
Read moreDirector Stewart Alan R. 🟢 acquired 4.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039291
Read moreJackson Andrew C. 🟢 acquired 14.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039289
Read moreDirector Schoeneck James A 🟢 acquired 5.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039288
Read morePoma Eric E 🟢 acquired 32.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039287
Read moreDirector Sanders Corazon (Corsee) D. 🟢 acquired 6.0K shares (1 derivative) of Calidi Biotherapeutics, Inc. (CLDI) at $1.36 Transaction Date: Aug 17, 2026 | Filing ID: 039285
Read moreNew Form SCHEDULE 13G/A - Calidi Biotherapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003562 <b>Size:</b> 10 KB
Read more(30% Negative) CALIDI BIOTHERAPEUTICS, INC. (CLDI) Reports Q3 2026 Financial Results
Read moreCalidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Read more